Trials / Completed
CompletedNCT03804671
A Study in Healthy Men to Measure the Amount of BI 730357 in the Blood When Taken as a Tablet
Investigation of Pharmacokinetics and Absolute Oral Bioavailability of BI 730357 Administered as an Oral Dose With an Intravenous Microtracer Dose of BI 730357 BS (C-14) in Healthy Male Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- Male
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
To investigate the absolute oral bioavailability of BI 730357 administered as tablet compared with \[C-14\]BI 730357 BS administered as intravenous microtracer
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BI 730357 | Oral dose |
| DRUG | BI 730357 mixed with [C-14] BI 730357 BS | Intravenous dose |
Timeline
- Start date
- 2019-01-31
- Primary completion
- 2019-03-26
- Completion
- 2019-03-26
- First posted
- 2019-01-15
- Last updated
- 2023-07-25
- Results posted
- 2023-07-25
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT03804671. Inclusion in this directory is not an endorsement.